TABUTEAU HERRIOT Insider Trading Activity (AXSM)

Profile

Herriot Tabuteau is the Chief Executive Officer of Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders. Under his leadership, the company has advanced several products in its pipeline aimed at addressing significant unmet medical needs.

Role	Insider
Notability	50/100

Board memberships

Axsome Therapeutics, Inc.

Awards & honors

Led the development of novel CNS therapies
Oversaw company growth and product pipeline expansion
Managed successful public offerings

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-07-01	AXSM	Axsome Therapeutics, Inc.	S — Open-market sale	49.7K	$240.25	$11.93M
2026-07-01	AXSM	Axsome Therapeutics, Inc.	M — Option exercise	49.7K	$4.95	$246K
2026-06-09	AXSM	Axsome Therapeutics, Inc.	S — Open-market sale	49.7K	$241.01	$11.97M
2026-06-09	AXSM	Axsome Therapeutics, Inc.	M — Option exercise	49.7K	$4.95	$246K
2026-02-02	AXSM	Axsome Therapeutics, Inc.	S — Open-market sale [10b5-1]	32.4K	$185.60	$6.02M
2026-02-02	AXSM	Axsome Therapeutics, Inc.	M — Option exercise [10b5-1]	32.4K	$8.02	$260K
2026-01-08	AXSM	Axsome Therapeutics, Inc.	S — Open-market sale [10b5-1]	31.3K	$170.38	$5.33M
2026-01-08	AXSM	Axsome Therapeutics, Inc.	M — Option exercise [10b5-1]	31.3K	$8.02	$251K
2026-01-08	AXSM	Axsome Therapeutics, Inc.	S — Open-market sale [10b5-1]	29.4K	$172.33	$5.08M
2026-01-08	AXSM	Axsome Therapeutics, Inc.	M — Option exercise [10b5-1]	29.4K	$8.02	$236K
2026-01-08	AXSM	Axsome Therapeutics, Inc.	S — Open-market sale [10b5-1]	78.7K	$171.28	$13.48M
2026-01-08	AXSM	Axsome Therapeutics, Inc.	M — Option exercise [10b5-1]	78.7K	$8.02	$631K
2025-12-05	AXSM	Axsome Therapeutics, Inc.	S — Open-market sale [10b5-1]	10.6K	$148.18	$1.56M
2025-12-05	AXSM	Axsome Therapeutics, Inc.	M — Option exercise [10b5-1]	10.6K	$8.02	$85K
2025-12-05	AXSM	Axsome Therapeutics, Inc.	S — Open-market sale [10b5-1]	20.2K	$146.94	$2.96M
2025-12-05	AXSM	Axsome Therapeutics, Inc.	M — Option exercise [10b5-1]	20.2K	$8.02	$162K
2025-12-05	AXSM	Axsome Therapeutics, Inc.	S — Open-market sale [10b5-1]	49.3K	$144.59	$7.12M
2025-12-05	AXSM	Axsome Therapeutics, Inc.	M — Option exercise [10b5-1]	49.3K	$8.02	$395K
2025-12-04	AXSM	Axsome Therapeutics, Inc.	S — Open-market sale [10b5-1]	10.6K	$148.18	$1.56M
2025-12-04	AXSM	Axsome Therapeutics, Inc.	M — Option exercise [10b5-1]	10.6K	$8.02	$85K

Frequently Asked Questions

Who is TABUTEAU HERRIOT?

How many SEC Form 4 filings has TABUTEAU HERRIOT submitted recently?

3 primary Form 4 filings in the last 90 days, covering 1 company.

Has TABUTEAU HERRIOT been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 21 open-market sales ($111.69M) across all tracked filings.

Where can I see all of TABUTEAU HERRIOT's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

TABUTEAU HERRIOT — SEC Form 4 Insider Trading Activity

Summary